Skip to main content

Table 3 List of common genes identified as differentially expressed by TCDD treatment from whole genome Agilent microarray analysis.

From: Differences in TCDD-elicited gene expression profiles in human HepG2, mouse Hepa1c1c7 and rat H4IIE hepatoma cells

Gene Symbol

Gene Name

Homologene ID

Fold changea

   

Human

Mouse

Rat

NQO1

NAD(P)H dehydrogenase, quinone 1

695

3.22

â–²

4.88

â–²

4.82

â–²

CCND1

cyclin D1

1334

1.57

â–²

-1.56

â–¼

-1.47

â–¼

ID3

inhibitor of DNA binding 3, dominant negative helix-loop-helix protein

1633

1.74

â–²

-1.83

â–¼

-1.68

â–¼

TIPARP

TCDD-inducible poly(ADP-ribose) polymerase

9167

1.47

â–²

7.05

â–²

2.91

â–²

POC1A

POC1 centriolar protein homolog A

51460

-1.64

â–¼

-1.67

â–¼

-1.57

â–¼

CYP1A1

cytochrome P450, family 1, subfamily A, polypeptide 1

68062

13.64

â–²

153.52

â–²

134.16

â–²

GSTA5

glutathione S-transferase A5

74378

-2.47

â–¼

1.47

â–²

5.85

â–²

UGT1A6

UDP glucuronosyltransferase 1 family, polypeptide A6

85959

2.09

â–²

2.24

â–²

2.06

â–²

MT1E

metallothionein 1E

108228

4.89

â–²

-1.66

â–¼

2.65

â–²

  1. aMaximum absolute foldchange determined by microarray analysis
  2. bDifferentially regulated genes with P1(t) > 0.999 and |foldchange| > 1.4